Target intelligence / Profile preview

Helicobacter pylori 50S ribosomal subunit (50S subunit)

Target
50S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The Helicobacter pylori 50S ribosomal subunit is the larger component of the bacterial 70S ribosome, playing a fundamental role in protein biosynthesis (UniProt). It is composed of 23S and 5S ribosomal RNA (rRNA) molecules along with approximately 33 ribosomal proteins (PubMed). The subunit contains the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, and the polypeptide exit tunnel through which the growing protein chain leaves the ribosome (StatPearls). This subunit is a primary target for several classes of antibiotics, including macrolides, lincosamides, and oxazolidinones (PubChem). In the context of H. pylori, macrolides like clarithromycin bind to the 23S rRNA to inhibit translation, making it a critical target for treating infections linked to gastritis, peptic ulcers, and gastric adenocarcinoma (NIH). However, the emergence of point mutations in the 23S rRNA has led to increasing rates of antibiotic resistance, complicating clinical management (PubMed). Monitoring these genetic biomarkers is increasingly important for tailoring antibiotic treatment to individual patients.

Other names
Large ribosomal subunit50S ribosomeH. pylori 50S subunit23S ribosomal RNA complex
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 23S rRNA of the 50S subunit, which prevents peptidyl transfer or blocks the ribosomal exit tunnel, thereby halting the elongation of the polypeptide chain (StatPearls, PubMed).

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activity
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric cancer
05

Safety considerations

Development of antimicrobial resistanceGastrointestinal side effectsAlteration of gut microbiota (dysbiosis)Drug-drug interactions (e.g., CYP3A4 inhibition by macrolides)QT interval prolongation
06

Interacting drugs

Clarithromycin

8 more in the full profile.

07

Biomarkers

23S rRNA gene mutations (e.g., A2142G, A2143G, A2142C)Clarithromycin susceptibility

Beyond the preview

Go deeper on Helicobacter pylori 50S ribosomal subunit (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori 50S ribosomal subunit (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call